Remdesivir Market Executive Summary, Review, Demand And Forecast To 2032 | Gilead Sciences Inc., Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Cipla, Pfizer

The Business Research Company’s Remdesivir Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Remdesivir Global Market Report 2023 evaluates remdesivir market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):

The global remedisiver market grew from $3.77 billion in 2022 to $4.95 billion in 2023 at a compound annual growth rate (CAGR) of 31.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The remedisiver market is expected to grow from $12.55 billion in 2027 at a CAGR of 26.2%.

The Remdesivir Market Segments In The Report Are:
Remdesivir Market By Route Of Administration:

Remdesivir Market By Dosage Form:
Frozen Solution
Lypholized Solution

Remdesivir Market By Distribution Channel:
Drug Stores/Pharmacies
Other Distribution Channels

Get More Information On The Remdesivir Market Report

Top 5 Major Key Players Are:
Gilead Sciences Inc
Bright Gene
Hainan Haiyao
Kelun Pharma
Hunan Warrant Pharmaceutical

Table Of Contents
1. Executive Summary
2. Remdesivir Market Characteristics
3. Remdesivir Market Trends And Strategies
4. Remdesivir Markett – Macro Economic Scenario
5. Remdesivir Market Size And Growth
27. Remdesivir Market Competitive Landscape And Company Profiles
28. Remdesivir Pipeline Analysis
29. Key Mergers And Acquisitions In The Remdesivir Market
30. Remdesivir Market Future Outlook and Potential Analysis
31. Appendix

List Of Tables
Table 1: Global Historic Market Growth, 2017-2022, $ Billion
Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3: Global Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4: Global Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5: Global Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 46: Gilead Sciences, Inc. Financial Performance
Table 47: Bright Gene Financial Performance
Table 48: Hainan Haiyao Financial Performance
Table 49: Kelun Pharma Financial Performance
Table 50: Hunan Warrant Pharmaceutical Financial Performance

Read Related Reports

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

 Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
Healthcare Blog:
Global Market Model: